Showing results (941-950 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|September 18, 2018
Application of Bayesian analyses to doubly randomized delayed start, matched control designs to demonstrate disease modificationIbrahim Turkoz, Marc Sobel, Larry AlphsPharmaceutical Statistics|September 1, 2018
Reasonable two-stage adaptive designs for single-arm phase II clinical trialsKosuke Kashiwabara, Yutaka MatsuyamaPharmaceutical Statistics|May 26, 2018
Missing data handling in non-inferiority and equivalence trials: A systematic reviewBrooke A Rabe, Simon Day, Mallorie H Fiero, et al.Pharmaceutical Statistics|September 5, 2025
Comparing Estimation Methods for the Area Under the Bi-Weibull ROC CurveRuhul Ali Khan, Musie GhebremichaelPharmaceutical Statistics|August 30, 2008
Use of simulation to compare the performance of minimization with stratified blocked randomizationRobert Toorawa, Michael Adena, Mark Donovan, et al.Pharmaceutical Statistics|December 17, 2008
Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programmeJohn Whitehead, Patrick Kelly, Yinghui Zhou, et al.Pharmaceutical Statistics|December 10, 2008
A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpointsHaiyan Xu, Isaac Nuamah, Jingyi Liu, et al.Pharmaceutical Statistics|July 24, 2009
The time course of drug effectsHesham S Al-Sallami, Venkata V Pavan Kumar, Cornelia B Landersdorfer, et al.Pharmaceutical Statistics|January 20, 2009
Statistical inference of risk difference in K correlated 2 x 2 tables with structural zeroShun-Fang Wang, Nian-Sheng Tang, Bo Zhang, et al.Pharmaceutical Statistics|July 18, 2009
Leveraging prior quantitative knowledge in guiding pediatric drug development: a case studyPravin R Jadhav, Jialu Zhang, Jogarao V S GobburuPageof 120